These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8117716)

  • 1. Fibrin-bound lipoprotein(a) promotes plasminogen binding but inhibits fibrin degradation by plasmin.
    Liu J; Harpel PC; Gurewich V
    Biochemistry; 1994 Mar; 33(9):2554-60. PubMed ID: 8117716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator.
    Liu JN; Harpel PC; Pannell R; Gurewich V
    Biochemistry; 1993 Sep; 32(37):9694-700. PubMed ID: 8373773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
    Anglés-Cano E; Hervio L; Rouy D; Fournier C; Chapman JM; Laplaud M; Koschinsky ML
    Chem Phys Lipids; 1994 Jan; 67-68():369-80. PubMed ID: 8187237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
    Rouy D; Grailhe P; Nigon F; Chapman J; Anglés-Cano E
    Arterioscler Thromb; 1991; 11(3):629-38. PubMed ID: 1827591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein (a) regulates plasmin generation and inhibition.
    Edelberg J; Pizzo SV
    Chem Phys Lipids; 1994 Jan; 67-68():363-8. PubMed ID: 8187236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA; Mangel WF
    Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
    Harpel PC; Gordon BR; Parker TS
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3847-51. PubMed ID: 2524834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis.
    Hervio L; Durlach V; Girard-Globa A; Anglés-Cano E
    Biochemistry; 1995 Oct; 34(41):13353-8. PubMed ID: 7577920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E; de la Peña Díaz A; Loyau S
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.
    Harpel PC; Chang VT; Borth W
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10193-7. PubMed ID: 1438209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin--a study with individual plasmas presenting natural variations of Lp(a).
    Soulat T; Loyau S; Baudouin V; Durlach V; Gillery P; Garnotel R; Loirat C; Anglés-Cano E
    Thromb Haemost; 1999 Jul; 82(1):121-7. PubMed ID: 10456465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity binding sites for human Glu-plasminogen unveiled by limited plasmic degradation of human fibrin.
    Tran-Thang C; Kruithof EK; Atkinson J; Bachmann F
    Eur J Biochem; 1986 Nov; 160(3):599-604. PubMed ID: 2946579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
    Bas Leerink C; Duif PF; Gimpel JA; Kortlandt W; Bouma BN; van Rijn HJ
    Thromb Haemost; 1992 Aug; 68(2):185-8. PubMed ID: 1412165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
    Rouy D; Koschinsky ML; Fleury V; Chapman J; Anglés-Cano E
    Biochemistry; 1992 Jul; 31(27):6333-9. PubMed ID: 1627572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation.
    Ezratty A; Simon DI; Loscalzo J
    Biochemistry; 1993 May; 32(17):4628-33. PubMed ID: 8485140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Lp(a) lipoprotein inhibit the fibrinolytic system?
    Halvorsen S; Skjønsberg OH; Berg K; Ruyter R; Godal HC
    Thromb Res; 1992 Nov; 68(3):223-32. PubMed ID: 1471070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) isoforms display differences in affinity for plasminogen-like binding to human mononuclear cells.
    Kang C; Durlach V; Soulat T; Fournier C; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2036-43. PubMed ID: 9351369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: An in vitro study using plasma from children with idiopathic nephrotic syndrome.
    Soulat T; Loyau S; Baudouin V; Maisonneuve L; Hurtaud-Roux MF; Schlegel N; Loirat C; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):575-84. PubMed ID: 10669658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.